Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder
Key facts
- Who runs it
- West Virginia University
- Where
- Morgantown, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 1 person enrolled
- Started
- 1 Jul 2023
- Ended
- 28 Jun 2024
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Deep Brain Stimulation
- Record updated
- 6 March 2026
Who can take part
- Age
- 22 years to 50 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- Age 22-50 years at time of enrollment
- Fulfills current DSM-5 diagnostic criteria for severe OUD with at least a 5-year history
- Participants may have comorbid SUD diagnoses at a mild, moderate or severe level, however, OUD must be the primary disorder for which the individual is seeking treatment and the other use disorders must occur in the context of relapse
- At least one lifetime overdose survival
- Demonstrated greater than five years of refractory symptoms of OUD
Who cannot take part
- Diagnosis of acute myocardial infarction or cardiac arrest 1 within the previous 6 months
- Past or present diagnosis of schizophrenia, psychotic disorder, bipolar disorder, or untreated depression other than one determined to be substance induced
- Unable to undergo MR-imaging
Where in United States
- West Virginia University Rockefeller Neuroscience InstituteMorgantown, United States
About the trial
What the trial wants to find out
The purpose of this clinical study is to investigate the safety, tolerability, and feasibility of Deep Brain Stimulation (DBS) of the nucleus accumbens (NAc) and ventral internal capsule (VC) for participants with treatment refractory opioid use disorder (OUD) who have cognitive, behavioral, and functional disability.
The 2 groups in the trial
- DBS-ON OnlyTreatment being tested
Titration will be based on stimulation parameters used in previous studies examining the role of DBS of the NAc in the treatment of OCD and depression as well as the parameters utilized in the initial pilot study conducted by the team. Participants receive active stimulation after surgery and throughout the remaineder of the study.
Treatment: Deep Brain Stimulation
- DBS-OFF, then DBS-ONSham treatment, for comparison
Titration sessions will be conducted identically to the "DBS-ON" arm, the only difference is that no stimulation is delivered for the first 12 weeks and therefore, no actual adjustments made. At Study Week 12, stimulation is turn on and continues for the remainder of the study.
Treatment: Deep Brain Stimulation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized, Sham-Controlled Trial Investigating Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder
- Record updated
- 6 March 2026